AIM
ELOS

Acrospire Investment Management’s Syneron Medical Ltd ELOS Stock Holding History

Acrospire Investment Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$30K Hold
2,738
– – 90.91% 1
2017
Q2 		$30K Sell
2,738
-600
-18% -$6.58K 0.03% 1298
2017
Q1 		$35K Sell
3,338
-28,161
-89% -$272K 0.03% 1260
2016
Q4 		$265K Buy
+31,499
New +$247K 0.11% 197

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Acrospire Investment Management's ELOS Position: Q3 2017 in Review

Acrospire Investment Management held its Syneron Medical Ltd (ELOS) position steady in Q3 2017 at 2,738 shares worth $30K. The position accounts for 90.91% of the portfolio, ranked #1.

Acrospire Investment Management first reported a position in ELOS in Q4 2016 and has held it in 4 quarters since. The position peaked at $265K in Q4 2016. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Acrospire Investment Management held 2,738 shares of Syneron Medical Ltd worth $30K as of Q3 2017.
  • Acrospire Investment Management left its Syneron Medical Ltd share count unchanged in Q3 2017.
  • Syneron Medical Ltd made up 90.91% of Acrospire Investment Management's portfolio in Q3 2017, its #1 holding.
  • Acrospire Investment Management first reported a position in Syneron Medical Ltd in Q4 2016 and has held it in 4 quarters since.
  • Acrospire Investment Management's Syneron Medical Ltd position peaked at $265K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.